May 13, 2020 / 10:17 PM / 12 days ago

BRIEF-Oncocyte Announces New Data To Be Presented At The 2020 ASCO

May 13 (Reuters) - OncoCyte Corp:

* ONCOCYTE ANNOUNCES NEW DATA TO BE PRESENTED AT THE 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING DEMONSTRATING THAT THE DETERMAIO™ GENE EXPRESSION TEST MAY PREDICT RESPONSE TO IMMUNOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below